Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hyperthermia × spartalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 22 Melanoma 21 Neoplasm Metastasis 19 Colorectal Neoplasms 17 Carcinoma, Hepatocellular 16 Triple Negative Breast Neoplasms 12 Pancreatic Neoplasms 12 Neoplasms 11 Nasopharyngeal Carcinoma 11 Squamous Cell Carcinoma of Head and Neck 9 Carcinoma, Renal Cell 9 Rectal Neoplasms 8 Lymphoma 8 Uterine Cervical Neoplasms 7 Stomach Neoplasms 7 Locally Advanced Rectal Cancer 7 Esophageal Neoplasms 6 Breast Neoplasms 6 Lung Neoplasms 5 Advanced Solid Tumor 5 Sarcoma 4 Recurrence 4 Ovarian Neoplasms 4 Lymphoma, Extranodal NK-T-Cell 4 Liver Neoplasms 4 Head and Neck Neoplasms 4 Glioblastoma 4 Gastrointestinal Stromal Tumors 4 Esophageal Squamous Cell Carcinoma 4 Endometrial Neoplasms 4

Interventions

Diathermy 14 Radiotherapy 8 Cisplatin 4 Melphalan 3 Immune Checkpoint Inhibitors 3 Fluorouracil 3 Drug Therapy 3 Cytoreduction Surgical Procedures 3 tislelizumab 2 Radiation 2 Immunotherapy 2 Conization 2 Brachytherapy 2 spartalizumab 1 sodium thiosulfate 1 anlotinib 1 Surgical Procedures, Operative 1 Solutions 1 Paclitaxel 1 Mitomycin 1 Leucovorin 1 Laser Therapy 1 Laparotomy 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hyperthermia, Induced 1 Hydrogen Peroxide 1 Gemcitabine 1 Folfox protocol 1 Floxuridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06022692 2023-09-05

HEAIS001

Zhejiang Hospital

Phase 1/2 Completed

Gastrointestinal

Hyperthermia, Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡